Longevity Acquisition Corporation Right
LOACR
LOACR was delisted on the 19th of March, 2021.
9 hedge funds and large institutions have $423K invested in Longevity Acquisition Corporation Right in 2020 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 9 → 9 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
1% less capital invested
Capital invested by funds: $429K → $423K (-$6K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$116K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Trading
New York
|
-$412 |
LOACR Hedge Fund Activity: Q1 2020 in Review
9 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Longevity Acquisition Corporation Right (LOACR) for Q1 2020, worth a combined $423K — down 1.4% from $429K a quarter earlier.
Fund positioning in LOACR was balanced in Q1 2020: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Hudson Bay Capital Management, adding an estimated $116K. The largest seller was Walleye Trading, cutting an estimated $412.
- 9 institutional investors held Longevity Acquisition Corporation Right (LOACR) as of Q1 2020, unchanged from Q4 2019.
- Funds reported $423K of Longevity Acquisition Corporation Right stock for Q1 2020, down 1.4% quarter-over-quarter.
- 0 funds opened new Longevity Acquisition Corporation Right positions in Q1 2020 and 0 closed out.
- The largest Longevity Acquisition Corporation Right buyer in Q1 2020 was Hudson Bay Capital Management, an estimated $116K added.
- The largest Longevity Acquisition Corporation Right seller in Q1 2020 was Walleye Trading, an estimated $412 sold.
Based on aggregated 13F filings for Q1 2020.